GP

Gordon Paul Noronha

Director Director DIN 03521685
DIN 03521685 First appointment May 2011 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since May 2011
Shareholding value Locked Premium profile

About Gordon Paul Noronha

Gordon Paul Noronha has 15 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 03521685
Primary Designation Director
First Appointment 24 May 2011
Oldest Company Age 15 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Slovia Pharmaceuticals Private Limited U36912MH2011PTC217795
Director 24 May 2011 2011 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Slovia Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Gordon Paul Noronha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gordon Paul Noronha

Gordon Paul Noronha has 15 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Gordon Paul Noronha is associated with 0 companies as Director.

Gordon Paul Noronha has expertise in General Business.

Gordon Paul Noronha has 15 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available